Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00121095
Recruitment Status : Unknown
Verified December 2007 by Cytogen Corporation.
Recruitment status was:  Recruiting
First Posted : July 21, 2005
Last Update Posted : December 21, 2007
Information provided by:
Cytogen Corporation

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Estimated Study Completion Date : June 2008